JPH0925228A - Seamless soft capsule - Google Patents

Seamless soft capsule

Info

Publication number
JPH0925228A
JPH0925228A JP17743495A JP17743495A JPH0925228A JP H0925228 A JPH0925228 A JP H0925228A JP 17743495 A JP17743495 A JP 17743495A JP 17743495 A JP17743495 A JP 17743495A JP H0925228 A JPH0925228 A JP H0925228A
Authority
JP
Japan
Prior art keywords
agar
soft capsule
water
seamless soft
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP17743495A
Other languages
Japanese (ja)
Other versions
JP3879941B2 (en
Inventor
Toshio Kurobe
俊夫 黒部
Kazuhisa Samura
一久 佐村
Kazumi Nanbu
一美 南部
Masao Kawamura
政男 河村
Shigemitsu Osawa
重光 大沢
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Priority to JP17743495A priority Critical patent/JP3879941B2/en
Publication of JPH0925228A publication Critical patent/JPH0925228A/en
Application granted granted Critical
Publication of JP3879941B2 publication Critical patent/JP3879941B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain the coat of a seamless capsule which is easily degradable by using two kinds of materials as essential components and optionally adding an plasticizer and/or a stabilizer. SOLUTION: This coat of a seamless capsule is obtained by using Japan agar and an aqueous polymer as essential components. The aqueous polymer is selected from alginic acid or its salts, an alginic acid derivative, carrageenan and a pectin. The aqueous polymer is preferably added in an amount of 1-150 pts.wt. to 100 pts.wt. of the Japan agar. Optionally, 10-450 pts.wt. of a plasticizer (e.g. a sugar, a sugar alcohol, a polysaccharide or a polyhydric alcohol) is added to the above system based on 100 pts.wt. of the Japan agar. Further, 0.5-30 pts.wt. of a stabilizer is optionally added to the system based on 100 pts.wt. of the Japan agar. The obtained soft capsule easily dissolves even in water or a gastric juice and has little hygroscopicity. It is resistant to be soften, scarcely sticking to each other and also resistant against the coloring and deterioration of the coat. Further, it has properties such as escaping from allergy caused by an animal material.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、易崩壊性のゼラチンフ
リーのシームレスカプセル皮膜に関するものである。
FIELD OF THE INVENTION The present invention relates to an easily disintegrating gelatin-free seamless capsule film.

【0002】[0002]

【従来の技術】一般に、軟カプセル剤の皮膜は牛、豚な
どの動物の骨や皮を材料とするゼラチンを基材とし、こ
れにグリセリン、ソルビトールなどを配合して製造され
ている。しかしながら、ゼラチンはソフトカプセルの製
造に優れた特性を有する反面、異種蛋白質としての抗原
性の可能性、ペプタイド構造に由来する他の薬物との反
応する可能性-例えばアミノカルボニル反応による着色-
や崩壊延長の原因となる不溶化、過乾燥による割れ、吸
湿による張り付き等の物理化学的変化、ゼラチンの特異
臭などの課題を抱えている。そのため、ゼラチンの精
製、ゼラチンと反応性のある物質の配合の回避、包装に
よる調湿などで対応を図っているのが現状である。さら
に、市場での天然指向の高まりとともに、ゼラチン以外
の非動物性のソフトカプセル素材の開発が強く要望され
ている。そこで、これまでにゼラチンフリーのソフトカ
プセルの製造について様々な方法が提案されている。
2. Description of the Related Art Generally, a film of a soft capsule is produced by using gelatin, which is a material of bone or skin of animals such as cows and pigs, as a base material, and glycerin, sorbitol and the like are added thereto. However, while gelatin has excellent properties for the production of soft capsules, it has the potential of being an antigenicity as a heterologous protein and the possibility of reacting with other drugs derived from the peptide structure-for example, coloring by the aminocarbonyl reaction-
There are problems such as insolubilization that causes disintegration and extension, cracking due to overdrying, physicochemical changes such as sticking due to moisture absorption, and peculiar odor of gelatin. For this reason, the current situation is to purify gelatin, avoid blending substances that are reactive with gelatin, and adjust the humidity by packaging. Furthermore, with the increase of natural orientation in the market, there is a strong demand for development of non-animal soft capsule materials other than gelatin. Therefore, various methods have been proposed so far for producing gelatin-free soft capsules.

【0003】このうち比較的よく知られているものに、
アルギニン酸と多価金属イオン、アルギン酸とペクチ
ン、金属イオンの組み合わせによる軟カプセル化(特開
平03ー68508号、特開平03ー285654号、
特開昭61ー44810号、特開昭58ー210841
号)、カラギーナンと金属イオンによる方法(特開昭6
0ー12943号)、寒天ソフトカプセル(特開平01
ー193216号)、寒天と腸溶性剤皮、寒天とメタア
クリル酸の組み合わせ(特開平05ー32543号、特
開昭57ー32230号)などがある。これらのうち、
アルギン酸、カラギーナン及びペクチンと金属イオンと
の組み合わせでは、これら高分子物質とカルシウムイオ
ンとの反応による非常に強固なイオン結合を利用してカ
プセル化されるため、得られる皮膜は水不溶性である。
寒天及び寒天と他剤との組み合わせによるカプセル形成
も寒天の水への溶解度の低さを利用している。これらの
方法は、ゼラチンが抗原となる可能性及びアミノーカル
ボニル反応を回避できるものの、むしろ腸溶性皮膜とし
てのメリットが強調されている発明である。
Of these, the ones that are relatively well known are:
Soft encapsulation by a combination of alginic acid and polyvalent metal ions, alginic acid and pectin, and metal ions (JP-A 03-68508, JP-A 03-285654,
JP-A-61-44810, JP-A-58-210841
No.), a method using carrageenan and a metal ion (Japanese Patent Laid-Open Publication No. Sho 6-66
No. 0-12943), agar soft capsule (Japanese Patent Laid-Open No. 01-123
No. 193216), an agar and an enteric coating, and a combination of agar and methacrylic acid (JP-A-05-32543 and JP-A-57-32230). Of these,
The combination of alginic acid, carrageenan and pectin with metal ions is encapsulated by utilizing a very strong ionic bond due to the reaction between these polymeric substances and calcium ions, so that the obtained film is water-insoluble.
Capsule formation by agar and a combination of agar and other agents also utilizes the low solubility of agar in water. These methods are inventions in which the possibility that gelatin serves as an antigen and the amino-carbonyl reaction can be avoided, but rather the merit as an enteric coating is emphasized.

【0004】[0004]

【発明が解決しようとする課題】したがって、これら技
術で製造されたソフトカプセルは水及び胃液では崩壊し
にくい。また、アルギン酸、カラギーナン、ペクチンな
どを用いた皮膜では、製造過程で濃厚な塩化カルシウム
溶液等の溶液中に浸せきされるために、金属イオン等が
ソフトカプセル剤皮中に結合して存在する量以外に、金
属イオン及び塩素イオン等の陰イオンとして多量吸着さ
れ、通常のカプセル成型過程では、洗浄などによっても
除去が困難である。これら陰イオンはカプセルに内包さ
れた薬物の安定性への悪影響を及ぼし、またカプセル保
存時に皮膜構造のレオロジカルな性質の経時変化を起こ
すことが懸念される。
Therefore, the soft capsules produced by these techniques are unlikely to disintegrate in water and gastric juice. Also, in the case of a film using alginic acid, carrageenan, pectin, etc., since it is immersed in a solution such as a concentrated calcium chloride solution during the manufacturing process, in addition to the amount of metal ions etc. bound and present in the soft capsule skin, However, it is adsorbed in large amounts as anions such as metal ions and chloride ions, and is difficult to remove even by washing in the usual capsule molding process. These anions adversely affect the stability of the drug encapsulated in the capsule, and it is feared that the rheological properties of the film structure change with time during storage of the capsule.

【0005】さらに、このようなソフトカプセル剤皮
は、胃での崩壊性の良いカプセル剤皮とすることも重要
な課題である。このことからゼラチンの持つ問題を解決
し、水及び胃液で崩壊しやすく、安全で、安定な品質の
ゼラチンフリーのソフトカプセル皮膜とその製造法の開
発が強く要望されてきている。そこで本発明者らは、こ
れら高分子について詳細な検討を重ねた結果、以下に示
す手段により課題を解決できることを見出し本発明を完
成した。
Further, it is also an important issue to make such a soft capsule skin as a capsule skin having good disintegration in the stomach. From this, there has been a strong demand to solve the problems of gelatin, to develop a gelatin-free soft capsule film of safe and stable quality, which is easy to disintegrate in water and gastric juice, and a manufacturing method thereof. Therefore, the present inventors have completed the present invention by discovering that the problems can be solved by the means shown below as a result of detailed studies on these polymers.

【0006】[0006]

【課題を解決するための手段】本発明は、寒天及び水溶
性高分子を必須成分とするシームレスソフトカプセル皮
膜である。本発明はまた、シームレスソフトカプセル剤
において、皮膜が寒天及び水溶性高分子を必須構成成分
とするシームレスソフトカプセル剤である。本発明にお
けるシームレスソフトカプセル皮膜には、さらに可塑
剤、安定化剤を加えることができる。
The present invention is a seamless soft capsule film containing agar and a water-soluble polymer as essential components. The present invention is also a seamless soft capsule in which the film contains agar and a water-soluble polymer as essential constituents. A plasticizer and a stabilizer can be further added to the seamless soft capsule film of the present invention.

【0007】本発明における水溶性高分子物質とは、具
体的には例えばアルギン酸、その誘導体、ペクチン及び
カラギーナン等を意味し、これらの水溶性高分子物質を
1種若しくは2種以上組み合わせて使用してもよい。ア
ルギン酸は通常ナトリウム塩であるが、遊離体であるか
塩であるかには限定されず、また塩の種類にも限定され
ない。アルギン酸はいずれのM/G比及び重合度でもよ
く、皮膜の性状に合わせて選択される。また、アルギン
酸誘導体は、より具体的にはアルギン酸プロピレングリ
コールエステル等であり、エステル化度が10以上で、
いずれのM/G比、重合度を用いてもよい。ペクチンは種
々のタイプのものが入手可能であるが、高メトキシタイ
プ(エステル化度50%以上)又は低メトキシタイプ
(エステル化度25%〜45%)のいずれのエステル化
度のものを使用してもよい。カラギーナンは分子中に硫
酸基を有し、数種のタイプ(カッパ、イオタ、ラムダ)
が存在するが、本発明ではいずれのタイプでも利用でき
る。
The water-soluble polymer substance in the present invention specifically means, for example, alginic acid, its derivative, pectin and carrageenan, and these water-soluble polymer substances are used alone or in combination of two or more kinds. May be. Alginic acid is usually a sodium salt, but is not limited to a free form or a salt, and is not limited to a kind of salt. Alginic acid may have any M / G ratio and polymerization degree, and is selected according to the properties of the film. Further, more specifically, the alginic acid derivative is propylene glycol alginate, etc., and has a degree of esterification of 10 or more,
Any M / G ratio and degree of polymerization may be used. Various types of pectin are available, but either high methoxy type (esterification degree of 50% or more) or low methoxy type (esterification degree of 25% to 45%) is used. May be. Carrageenan has a sulfate group in the molecule and is of several types (kappa, iota, lambda).
However, any type can be used in the present invention.

【0008】また、本発明における可塑剤とは、例えば
糖、糖アルコール、多糖類及び多価アルコールから選ば
れる物質を意味し、これらの物質を1種若しくは2種以
上組み合わせて用いてもよい。
The plasticizer in the present invention means a substance selected from, for example, sugars, sugar alcohols, polysaccharides and polyhydric alcohols, and these substances may be used alone or in combination of two or more.

【0009】糖及び糖アルコールとしては、蔗糖、マル
トース、グルコース、ソルビトール、マルチトール、キ
シリトール、マンニトール、エリスリトール等を挙げる
ことができ、2種以上を用いてもよい。多価アルコール
としてはグリセリン、グリコール類としてポリエチレン
グリコール類(分子量400〜6000)等を挙げるこ
とができる。
Examples of sugars and sugar alcohols include sucrose, maltose, glucose, sorbitol, maltitol, xylitol, mannitol, erythritol, and two or more kinds may be used. Examples of the polyhydric alcohol include glycerin, and examples of the glycols include polyethylene glycols (molecular weight 400 to 6000).

【0010】多糖類としてパインデックスなどのデキス
トリン類、部分アルファ化でんぷん(例えば商品名PCS
として旭化成株式会社より入手できる)が使用できる。
As the polysaccharides, dextrins such as pa index, partially pregelatinized starch (eg, trade name PCS
(Available from Asahi Kasei Co., Ltd.) can be used.

【0011】本発明にはまた、安定化剤を使用すること
ができる。安定化剤とは、アミノ酸、界面活性剤、有機
酸若しくはそれらの塩類及び無機酸を意味する。アミノ
酸の具体的な例としては、アスパラギン酸、リジン、グ
リシン、セリン、アラニン、ヒスチジン、フェニルアラ
ニンなどを挙げることができる。また、界面活性剤は水
素添加硬化ヒマシ油ポリオキシエチレン誘導体、蔗糖脂
肪酸エステル類、ポリソルベートなどを挙げることがで
きる。 有機酸、無機酸は例えば、クエン酸、リンゴ
酸、フマル酸、酒石酸、乳酸、リン酸、塩酸等であり、
これらは塩であってもよい。
Stabilizers can also be used in the present invention. The stabilizer means an amino acid, a surfactant, an organic acid or salts thereof, and an inorganic acid. Specific examples of amino acids include aspartic acid, lysine, glycine, serine, alanine, histidine, and phenylalanine. Examples of the surfactant include hydrogenated hydrogenated castor oil polyoxyethylene derivative, sucrose fatty acid ester, and polysorbate. Organic acids, inorganic acids are, for example, citric acid, malic acid, fumaric acid, tartaric acid, lactic acid, phosphoric acid, hydrochloric acid,
These may be salts.

【0012】本発明における水溶性高分子の寒天に対す
る比率は特に限定されないが、通常は寒天100重量部
に対して水溶性高分子1〜150重量部であり、好まし
くは10〜120重量部であり、より好ましくは15〜
100重量部である。また、可塑剤の寒天に対する比率
は特に限定されないが、通常は寒天100重量部に対し
て可塑剤が10〜450重量部であり、好ましくは20
〜300重量部、より好ましくは30〜230重量部で
ある。
The ratio of the water-soluble polymer to the agar in the present invention is not particularly limited, but it is usually 1 to 150 parts by weight, preferably 10 to 120 parts by weight with respect to 100 parts by weight of the agar. , More preferably 15 to
100 parts by weight. The ratio of the plasticizer to the agar is not particularly limited, but is usually 10 to 450 parts by weight, preferably 20 parts by weight, relative to 100 parts by weight of the agar.
To 300 parts by weight, more preferably 30 to 230 parts by weight.

【0013】安定化剤の寒天に対する比率は、特に限定
されないが通常は寒天100重量に対して、安定化剤が
0.5〜30重量部であり、好ましくは1〜25重量部、
より好ましくは3〜20重量部である。本発明における
寒天は、市販のものをそのまま用いることができる。
The ratio of the stabilizer to the agar is not particularly limited, but the stabilizer is usually added to 100 parts by weight of the agar.
0.5 to 30 parts by weight, preferably 1 to 25 parts by weight,
It is more preferably 3 to 20 parts by weight. As the agar in the present invention, commercially available agar can be used as it is.

【0014】本発明におけるソフトカプセルは次の方法
で製造することができる。寒天、水溶性高分子、糖ある
いはグリセリンを十分混和し、加温用ジャケット付タン
クなどで予め60〜70℃に加温した温水中に攪拌しな
がら、少量ずつ加え、均一に分散させる。さらに、80
〜98℃で攪拌下に加温し溶解させる。液の透明感、ダ
マの消失、溶状の均質性を確認後、穏やかに攪拌しなが
ら冷却する。液温が50〜70℃に達した時点で、安定
化剤を添加し、溶解させ皮膜液を得る。次いで通常の方
法で目的としたシームレスカプセルを製造する。カプセ
ル皮膜には必要により色素、保存剤などを添加すること
ができる。
The soft capsule of the present invention can be manufactured by the following method. Agar, water-soluble polymer, sugar or glycerin are sufficiently mixed, and the mixture is added little by little while stirring in warm water previously heated to 60 to 70 ° C. in a tank with a heating jacket or the like, and uniformly dispersed. In addition, 80
Warm under stirring at ~ 98 ° C to dissolve. After confirming the transparency of the liquid, disappearance of lumps, and homogeneity of the liquid state, cool with gentle stirring. When the liquid temperature reaches 50 to 70 ° C., a stabilizer is added and dissolved to obtain a film liquid. Then, the intended seamless capsule is produced by a usual method. If necessary, a dye, a preservative and the like can be added to the capsule film.

【0015】本発明によるソフトカプセルは以下のよう
な点で優れた性質を有する。 1)易崩壊性で、水、胃液においても容易に溶解する。
2)吸湿性が少ない。軟化しずらい。カプセル同志のハ
リツキが起こりにくい。3)アミノカルボニル反応に起
因する皮膜の着色、劣化を起こしにくい。4)動物素材
に起因するアレルギーの可能性が回避される。
The soft capsule according to the present invention has excellent properties in the following points. 1) It is easily disintegrating and dissolves easily in water and gastric juice.
2) Low hygroscopicity. Hard to soften. Hardness of capsule comrades is unlikely to occur. 3) Coloring and deterioration of the film due to the aminocarbonyl reaction are unlikely to occur. 4) The possibility of allergies due to animal material is avoided.

【0016】本発明によるカプセル皮膜の構成のメカニ
ズムは以下のように考えられる。寒天は加温溶存時、分
子がランダムコイル状態で存在する。温度の低下ととも
にダブルへリックス構造の三次元ネットワークを取り、
ゲルが形成される(ゾルーゲル転移30〜50℃)。こ
れは熱可塑性である(融点85〜93℃)。すなわち寒
天ゲルはその構成成分のひとつであるアガロペクチンの
酸性基を利用し強アルカリ性にするか、融点以上に加温
しない限り、水への溶解は難しい。本発明においては寒
天の強固なネットワーク構造がカプセル皮膜の骨格を形
成しているものと考えられる。一方、アルギン酸、ペク
チン、カラギーナンは、これら単独ではもろいゲルとな
り成型性に劣る。ゲル強度の強い寒天をベースとして比
較的強いネットワークを造り、そのネットワークの中へ
アルギン酸、ペクチン等の親水性物質を入り込ませるこ
とにより、ネットワーク内への水の導入経路が構築さ
れ、皮膜の崩壊性を高めることが可能となったと考えら
れる。ここで用いられる親水性物質は、前述の水溶性高
分子のアルギン酸ナトリウム、アルギン酸プロピレング
リコール、ペクチン、カラギーナンであり、さらに可塑
剤の糖、糖アルコール、多価アルコール、多糖類、安定
化剤のアミノ酸、有機酸塩、無機酸塩である。
The mechanism of the constitution of the capsule coating according to the present invention is considered as follows. When agar is dissolved by heating, molecules exist in a random coil state. Taking a three-dimensional network of double helix structure as the temperature decreases,
A gel is formed (sol-gel transition 30-50 ° C). It is thermoplastic (melting point 85-93 ° C). That is, agar gel is difficult to dissolve in water unless it is made strongly alkaline by utilizing the acidic group of agaropectin, which is one of its constituents, or it is heated above its melting point. In the present invention, it is considered that the strong agar network structure forms the skeleton of the capsule film. On the other hand, alginic acid, pectin, and carrageenan are fragile gels when used alone, and are inferior in moldability. By creating a relatively strong network based on agar, which has a strong gel strength, and by allowing hydrophilic substances such as alginic acid and pectin to enter into the network, a pathway for introducing water into the network is constructed and the disintegration of the film It is thought that it has become possible to increase the The hydrophilic substances used here are the water-soluble polymers sodium alginate, propylene glycol alginate, pectin, and carrageenan, and further sugars as plasticizers, sugar alcohols, polyhydric alcohols, polysaccharides, amino acids as stabilizers. , Organic acid salts and inorganic acid salts.

【0017】[0017]

【実施例】以下に本発明を実施例を挙げて詳細に説明す
るが、本発明はこれらの実施例に限定されない。 実施例1 寒天28g、ソルビット15gを精製水2000mlに
分散させ、煮沸溶解する。寒天が完全に溶解した後、6
0〜70℃に冷却し、次いでアルギン酸プロピレングリ
コール6g、グリセリン20g、リンゴ酸ナトリウム1
gの混和物を加えて溶解し皮膜液とする。常法にしたが
って薬物を溶解した綿実油を内溶液とするシームレスソ
フトカプセルを得た。
EXAMPLES The present invention is described in detail below with reference to examples, but the present invention is not limited to these examples. Example 1 28 g of agar and 15 g of sorbit are dispersed in 2000 ml of purified water and dissolved by boiling. 6 after the agar has completely dissolved
Cool to 0-70 ° C., then propylene glycol alginate 6 g, glycerin 20 g, sodium malate 1
g of the mixture is added and dissolved to form a film solution. According to a conventional method, seamless soft capsules containing cottonseed oil in which a drug was dissolved as an internal solution were obtained.

【0018】実施例2 寒天50g、ソルビット30gを精製水2000mlに
分散させ、煮沸溶解する。寒天が完全に溶解した後、約
60℃に冷却、保温し、次いでアルギン酸プロピレング
リコール18g、グリセリン34g、アスパラギン酸2
g、ソルビット5gおよびクエン酸二水素ナトリウム1.
5g のの混和物を均一に溶解し、皮膜液とし、実施例1
と同様にして、内溶液とするシームレスソフトカプセル
を得た。
Example 2 50 g of agar and 30 g of sorbit are dispersed in 2000 ml of purified water and dissolved by boiling. After the agar was completely dissolved, it was cooled to about 60 ° C and kept warm, then 18 g of propylene glycol alginate, 34 g of glycerin, 2 parts of aspartic acid.
g, sorbitol 5 g and sodium dihydrogen citrate 1.
Example 1 was prepared by uniformly dissolving 5 g of the mixture to obtain a film solution.
In the same manner as described above, seamless soft capsules as an internal solution were obtained.

【0019】実施例3 寒天45gを精製水1500mlに分散させ、蒸発溶解
する。寒天が完全に溶解した後、50〜60℃に冷却、
保温し、ペクチン13g、グリセリン20g、アラニン
2.5gの混和物を溶解して皮膜液を製造し、実施例1と同
様にシームレスソフトカプセルを得た。
Example 3 45 g of agar was dispersed in 1500 ml of purified water, and dissolved by evaporation. After the agar is completely dissolved, cool to 50-60 ° C,
Keep warm, pectin 13g, glycerin 20g, alanine
2.5 g of the mixture was dissolved to produce a film liquid, and seamless soft capsules were obtained in the same manner as in Example 1.

【0020】実施例4 寒天40gとグリセリン25gを混和後、精製水210
0mlに分散させ、煮沸溶解する。寒天が完全に溶解し
た後、60〜70℃に冷却、保温し、次いでカラギーナ
ン30g、ソルビット5g、グリシン4g、クエン酸二
水素ナトリウム1gの混和物を加えて溶解し皮膜液を得
た。実施例1と同様にしてシームレスソフトカプセルを
得た。
Example 4 After mixing 40 g of agar and 25 g of glycerin, purified water 210 was added.
Disperse in 0 ml and dissolve by boiling. After the agar was completely dissolved, the mixture was cooled to 60 to 70 ° C. and kept warm, and then a mixture of 30 g of carrageenan, 5 g of sorbit, 4 g of glycine and 1 g of sodium dihydrogen citrate was added and dissolved to obtain a film solution. Seamless soft capsules were obtained in the same manner as in Example 1.

【0021】比較例1 寒天50g、グリセリン25gを精製水2000mlに
分散させ、煮沸溶解する。これを比較皮膜とし、実施例
1と同様にシームレスソフトカプセルを得た。 比較例2 ゼラチン20g、グリセリン6gを精製水1000ml
に分散させ、70〜80℃に加温、溶解する。これを比
較皮膜とし、実施例1と同様にシームレスソフトカプセ
ルを得た。実施例1〜4及び比較例1〜2について、製
造直後、冷凍庫(ー20℃)、45℃、40℃75%R
Hの各条件での1週間、1〜3ヶ月間保存後のカプセル
の諸物性を測定し表1〜4に示した。表5には、ゼラチ
ンカプセルと本発明による寒天系カプセルの特徴を要約
した。
Comparative Example 1 50 g of agar and 25 g of glycerin are dispersed in 2000 ml of purified water and dissolved by boiling. Using this as a comparative film, seamless soft capsules were obtained in the same manner as in Example 1. Comparative Example 2 20 g of gelatin and 6 g of glycerin were added to 1000 ml of purified water.
Disperse in, and heat at 70-80 ° C. to dissolve. Using this as a comparative film, seamless soft capsules were obtained in the same manner as in Example 1. Regarding Examples 1 to 4 and Comparative Examples 1 and 2, immediately after production, a freezer (−20 ° C.), 45 ° C., 40 ° C. 75% R
Various physical properties of the capsules after storage for 1 week and 1 to 3 months under each condition of H were measured and shown in Tables 1 to 4. Table 5 summarizes the characteristics of the gelatin capsule and the agar-based capsule according to the present invention.

【表1】 [Table 1]

【表2】 [Table 2]

【表3】 [Table 3]

【表4】 [Table 4]

【表5】 [Table 5]

Claims (11)

【特許請求の範囲】[Claims] 【請求項1】寒天及び水溶性高分子を必須成分とするシ
ームレスソフトカプセル皮膜。
1. A seamless soft capsule film containing agar and a water-soluble polymer as essential components.
【請求項2】寒天、水溶性高分子及び可塑剤からなるシ
ームレスソフトカプセル皮膜。
2. A seamless soft capsule film comprising agar, a water-soluble polymer and a plasticizer.
【請求項3】寒天、水溶性高分子、可塑剤及び安定化剤
からなるシームレスソフトカプセル皮膜。
3. A seamless soft capsule film comprising agar, a water-soluble polymer, a plasticizer and a stabilizer.
【請求項4】水溶性高分子がアルギン酸若しくはその
塩、アルギン酸誘導体、カラギーナン及びペクチンから
選ばれる1以上の物質である請求項1ないし3いずれか
1項記載のシームレスソフトカプセル皮膜。
4. The seamless soft capsule film according to claim 1, wherein the water-soluble polymer is one or more substances selected from alginic acid or a salt thereof, an alginic acid derivative, carrageenan and pectin.
【請求項5】可塑剤が糖、糖アルコール、多糖類及び多
価アルコールから選ばれる1以上の物質である請求項2
又は3記載のシームレスソフトカプセル皮膜。
5. The plasticizer is one or more substances selected from sugars, sugar alcohols, polysaccharides and polyhydric alcohols.
Or the seamless soft capsule film described in 3.
【請求項6】安定化剤がアミノ酸、界面活性剤、有機酸
若しくはその塩類及び無機酸から選ばれる1以上の物質
である請求項3記載のソフトカプセル皮膜。
6. The soft capsule film according to claim 3, wherein the stabilizer is one or more substances selected from amino acids, surfactants, organic acids or salts thereof, and inorganic acids.
【請求項7】寒天100重量部に対して水溶性高分子が
1〜150重量部である請求項1〜3いずれか1項記載
のシームレスソフトカプセル皮膜。
7. The seamless soft capsule film according to claim 1, wherein the water-soluble polymer is 1 to 150 parts by weight with respect to 100 parts by weight of agar.
【請求項8】寒天100重量部に対して可塑剤が10〜
450重量部である請求項2又は3記載のシームレスソ
フトカプセル皮膜。
8. A plasticizer of 10 parts by weight per 100 parts by weight of agar.
The seamless soft capsule film according to claim 2, which is 450 parts by weight.
【請求項9】寒天100重量部に対して、安定化剤が0.
5〜30重量部である請求項3記載のシームレスソフト
カプセル皮膜。
9. Stabilizer is added to 100 parts by weight of agar in an amount of 0.
The seamless soft capsule film according to claim 3, which is 5 to 30 parts by weight.
【請求項10】シームレスソフトカプセル剤において、
皮膜が寒天及び水溶性高分子を必須構成成分とするシー
ムレスソフトカプセル剤。
10. In a seamless soft capsule,
A seamless soft capsule whose film contains agar and water-soluble polymer as essential components.
【請求項11】水溶性高分子がアルギン酸及びアルギン
酸誘導体、カラギーナン、ペクチンである請求項10記
載のシームレスソフトカプセル剤。
11. The seamless soft capsule according to claim 10, wherein the water-soluble polymer is alginic acid, an alginic acid derivative, carrageenan, or pectin.
JP17743495A 1995-07-13 1995-07-13 Seamless soft capsule Expired - Fee Related JP3879941B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP17743495A JP3879941B2 (en) 1995-07-13 1995-07-13 Seamless soft capsule

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17743495A JP3879941B2 (en) 1995-07-13 1995-07-13 Seamless soft capsule

Publications (2)

Publication Number Publication Date
JPH0925228A true JPH0925228A (en) 1997-01-28
JP3879941B2 JP3879941B2 (en) 2007-02-14

Family

ID=16030885

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17743495A Expired - Fee Related JP3879941B2 (en) 1995-07-13 1995-07-13 Seamless soft capsule

Country Status (1)

Country Link
JP (1) JP3879941B2 (en)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2767070A1 (en) * 1997-08-08 1999-02-12 Laurence Paris AQUEOUS VISCOUS COMPOSITION, LIMPID OR NOT, FOR THE MANUFACTURE OF SOFT CAPSULES AND HARD CAPSULES, AND METHOD FOR MANUFACTURING FILMS FOR SUCH CAPSULES
WO2000027367A1 (en) * 1998-11-11 2000-05-18 Bioprogress Technology International Incorporated A capsule based drug delivery system
US6340473B1 (en) 1999-07-07 2002-01-22 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
WO2003084516A1 (en) * 2002-04-04 2003-10-16 Fmc Biopolymer As Polysaccharide capsules and methods of preparation
KR100814034B1 (en) * 2006-11-27 2008-03-14 (주)아모레퍼시픽 Cosmetic capsule composition and its manufacturing method
JP2008546400A (en) * 2005-06-21 2008-12-25 ヴェ. マヌ フィル Smoking device incorporating a collapsible capsule, collapsible capsule, and method of manufacturing the capsule
US7766637B2 (en) 2006-03-03 2010-08-03 Fmc Corporation Method and apparatus for the preparation of capsules
JP2013504574A (en) * 2009-09-10 2013-02-07 エフ エム シー コーポレーション Seamless alginate capsules with high strength
JP2013139419A (en) * 2011-12-30 2013-07-18 Sansho Kaken Kk Method for producing softgel type external preparation, softening liquid, and softgel type external preparation
WO2015115072A1 (en) 2014-01-31 2015-08-06 富士カプセル株式会社 Capsule formulation
WO2018225770A1 (en) * 2017-06-09 2018-12-13 富士カプセル株式会社 Seamless capsule coating composition and seamless capsule
JP2019112383A (en) * 2017-12-26 2019-07-11 三生医薬株式会社 Method of producing soft capsule
JP2021516257A (en) * 2018-03-02 2021-07-01 キャプテック ソフトジェル インターナショナル、インコーポレイテッド Softgel composition and capsules made from it
JP7231796B1 (en) * 2021-12-24 2023-03-01 株式会社カマタ SEAMLESS CAPSULE AND METHOD FOR PRODUCING THE SAME
CN116725974A (en) * 2023-07-03 2023-09-12 华侨大学 Application of gel composition in preparation of medical compressed plant source soft capsules
EP4041022A4 (en) * 2019-10-09 2023-11-01 R.P. Scherer Technologies, LLC NON-ANIMAL SOFT GEL CAPSULE FORMULATIONS, METHOD FOR THEIR PRODUCTION AND USE THEREOF
JPWO2025142831A1 (en) * 2023-12-28 2025-07-03

Cited By (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2767070A1 (en) * 1997-08-08 1999-02-12 Laurence Paris AQUEOUS VISCOUS COMPOSITION, LIMPID OR NOT, FOR THE MANUFACTURE OF SOFT CAPSULES AND HARD CAPSULES, AND METHOD FOR MANUFACTURING FILMS FOR SUCH CAPSULES
WO1999007347A1 (en) * 1997-08-08 1999-02-18 Laurence Paris Aqueous viscous compositions, whether clear or not, for making soft or hard capsules, and method for making films for such capsules
WO2000027367A1 (en) * 1998-11-11 2000-05-18 Bioprogress Technology International Incorporated A capsule based drug delivery system
USRE39079E1 (en) * 1999-07-07 2006-04-25 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
US6582727B2 (en) 1999-07-07 2003-06-24 R. P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
US6340473B1 (en) 1999-07-07 2002-01-22 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
WO2003084516A1 (en) * 2002-04-04 2003-10-16 Fmc Biopolymer As Polysaccharide capsules and methods of preparation
US7972620B2 (en) 2002-04-04 2011-07-05 Fmc Biopolymer As Polysaccharide capsules and methods of preparation
US9017720B2 (en) 2002-04-04 2015-04-28 FMC Bioploymer AS Polysaccharide capsules and method of preparation
JP2014166188A (en) * 2005-06-21 2014-09-11 V Mane Fils Smoking device incorporating breakable capsule, breakable capsule, and production method for capsule
US10278418B2 (en) 2005-06-21 2019-05-07 V. Mane Fils Smoking device incorporating a breakable capsule, breakable capsule and process for manufacturing said capsule
JP2008546400A (en) * 2005-06-21 2008-12-25 ヴェ. マヌ フィル Smoking device incorporating a collapsible capsule, collapsible capsule, and method of manufacturing the capsule
US9339060B2 (en) 2005-06-21 2016-05-17 V. Mane Fils Smoking device incorporating a breakable capsule, breakable capsule and process for manufacturing said capsule
JP2015037425A (en) * 2005-06-21 2015-02-26 ヴェ. マヌ フィル Smoking device incorporating breakable capsule, breakable capsule, and production method for capsule
US8820331B2 (en) 2005-06-21 2014-09-02 V. Mane Fils Smoking device incorporating a breakable capsule, breakable capsule and process for manufacturing said capsule
US8916192B2 (en) 2006-03-03 2014-12-23 Fmc Corporation Method and apparatus for the preparation of capsules
US8153037B2 (en) 2006-03-03 2012-04-10 Fmc Corporation Method and apparatus for the preparation of capsules
US7766637B2 (en) 2006-03-03 2010-08-03 Fmc Corporation Method and apparatus for the preparation of capsules
KR100814034B1 (en) * 2006-11-27 2008-03-14 (주)아모레퍼시픽 Cosmetic capsule composition and its manufacturing method
JP2013504574A (en) * 2009-09-10 2013-02-07 エフ エム シー コーポレーション Seamless alginate capsules with high strength
US9895672B2 (en) 2009-09-10 2018-02-20 DuPont Nutrition USA, Inc. High strength seamless alginate capsules
JP2013139419A (en) * 2011-12-30 2013-07-18 Sansho Kaken Kk Method for producing softgel type external preparation, softening liquid, and softgel type external preparation
WO2015115072A1 (en) 2014-01-31 2015-08-06 富士カプセル株式会社 Capsule formulation
US11364206B2 (en) 2017-06-09 2022-06-21 Fuji Capsule Co., Ltd. Seamless capsule shell composition and seamless capsule
WO2018225770A1 (en) * 2017-06-09 2018-12-13 富士カプセル株式会社 Seamless capsule coating composition and seamless capsule
JPWO2018225770A1 (en) * 2017-06-09 2020-04-09 富士カプセル株式会社 Composition for seamless capsule film and seamless capsule
JP2019112383A (en) * 2017-12-26 2019-07-11 三生医薬株式会社 Method of producing soft capsule
JP2021516257A (en) * 2018-03-02 2021-07-01 キャプテック ソフトジェル インターナショナル、インコーポレイテッド Softgel composition and capsules made from it
EP4041022A4 (en) * 2019-10-09 2023-11-01 R.P. Scherer Technologies, LLC NON-ANIMAL SOFT GEL CAPSULE FORMULATIONS, METHOD FOR THEIR PRODUCTION AND USE THEREOF
AU2020363824B2 (en) * 2019-10-09 2026-01-08 R.P. Scherer Technologies, Llc Non-animal softgel capsule formulations, methods of preparation, and methods of use thereof
JP7231796B1 (en) * 2021-12-24 2023-03-01 株式会社カマタ SEAMLESS CAPSULE AND METHOD FOR PRODUCING THE SAME
WO2023119624A1 (en) * 2021-12-24 2023-06-29 株式会社カマタ Seamless capsule
CN116725974A (en) * 2023-07-03 2023-09-12 华侨大学 Application of gel composition in preparation of medical compressed plant source soft capsules
CN116725974B (en) * 2023-07-03 2025-12-30 华侨大学 Application of gel composition in the preparation of medical compressed plant-derived soft capsules
JPWO2025142831A1 (en) * 2023-12-28 2025-07-03

Also Published As

Publication number Publication date
JP3879941B2 (en) 2007-02-14

Similar Documents

Publication Publication Date Title
JP3879941B2 (en) Seamless soft capsule
US20250099376A1 (en) Pharmaceutical composition comprising ghb gastro-retentive raft forming systems having trigger pulse drug release
ES2603225T3 (en) Soft capsule system without gelatin
TWI472323B (en) Aqueous composition for enteric hard capsule, method of preparing enteric hard capsule,and enteric hard capsule prepared using the method
JP3455962B2 (en) Cellulose capsule using mixed solution of pectin and glycerin and method for producing the same
CA2360647C (en) Fast dispersing dosage forms free of gelatin
JP4184278B2 (en) Non-gelatin capsule coating composition and capsule using the same
JP4294862B2 (en) Gelatin composition
US6509040B1 (en) Fast dispersing dosage forms essentially free of mammalian gelatin
US5874106A (en) Filled gelatin capsules
CN103087208B (en) By the carrageenin of ion exchange method modification
JP3672008B2 (en) Hard capsule and method for producing the same
KR102785453B1 (en) Gel mass composition for enteric soft capsule
JP5107584B2 (en) Functional jelly composition and method for producing the same
JP2001008634A (en) Soluble polymerized gelatin, its production and method for adjusting its solubility
WO2002064120A1 (en) Gel preparations for internal use
JPH0620534B2 (en) Water-soluble soft capsule
KR100886542B1 (en) Solubilization composition of sibutramine and preparation method thereof
KR101591713B1 (en) Process for preparing transparent soft capsule for acidic drug with flat form system which dissolves hydoxide ion species
KR102013296B1 (en) Aqueous composition for hard capsule, method of preparing the aqueous composition and hard capsule prepared thereof
JP2004250369A (en) Coating film composition for soft capsule
Bhowmik et al. Properties of Polymers Enabling In Situ Gel Formation
HK1037536B (en) Fast dispersing dosage forms free of gelatin

Legal Events

Date Code Title Description
A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20050408

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050603

A911 Transfer of reconsideration by examiner before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20050610

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20060705

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20061102

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20061102

R150 Certificate of patent (=grant) or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091117

Year of fee payment: 3

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101117

Year of fee payment: 4

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111117

Year of fee payment: 5

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111117

Year of fee payment: 5

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121117

Year of fee payment: 6

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131117

Year of fee payment: 7

LAPS Cancellation because of no payment of annual fees